CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
TOTAL REVENUE	$ 38,350	$ 62,898	$ 54,693
COST OF GOODS SOLD	(16,349)	(10,873)	(10,895)
RESEARCH AND DEVELOPMENT EXPENSES, NET	(29,734)	(38,167)	(44,616)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES	(12,729)	(11,148)	(9,899)
OPERATING INCOME (LOSS)	(20,462)	2,710	(10,717)
FINANCIAL EXPENSES	(7,521)	(9,671)	(7,966)
FINANCIAL INCOME	401	438	407
FINANCIAL EXPENSES - NET	(7,120)	(9,233)	(7,559)
NET LOSS FOR THE YEAR	$ (27,582)	$ (6,523)	$ (18,276)
LOSS PER SHARE OF COMMON STOCK - BASIC	$ (0.62)	$ (0.22)	$ (1.23)
LOSS PER SHARE OF COMMON STOCK - DILUTED	$ (0.62)	$ (0.22)	$ (1.23)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - BASIC	44,140,233	29,148,047	14,838,213
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE - DILUTED	44,140,233	29,148,047	14,838,213
Goods [Member]
TOTAL REVENUE	$ 16,749	$ 16,236	$ 15,866
License and R&D Services [Member]
TOTAL REVENUE	$ 21,601	$ 46,662	$ 38,827